Total Payments
$160,229
2024 Payments
$21.84
Companies
7
Transactions
142
Medicare Patients
590
Medicare Billing
$72,716
Payment Breakdown by Category
Other$102,290 (63.8%)
Travel$36,571 (22.8%)
Consulting$16,447 (10.3%)
Food & Beverage$4,818 (3.0%)
Education$104.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,290 | 37 | 63.8% |
| Travel and Lodging | $36,571 | 44 | 22.8% |
| Consulting Fee | $16,447 | 4 | 10.3% |
| Food and Beverage | $4,818 | 54 | 3.0% |
| Education | $104.12 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $136,788 | 88 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $18,972 | 46 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,185 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $99.00 | 1 | $0 (2019) |
| Sentynl Therapeutics, Inc. | $98.42 | 1 | $0 (2017) |
| Abbott Laboratories | $74.98 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $11.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.84 | 1 | Abbott Laboratories ($21.84) |
| 2023 | $53.14 | 2 | Abbott Laboratories ($53.14) |
| 2019 | $4,335 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($4,185) |
| 2018 | $77,086 | 65 | INSYS Therapeutics Inc ($73,452) |
| 2017 | $78,733 | 68 | INSYS Therapeutics Inc ($63,336) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Heart Failure | ||||||
| 12/20/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Heart Failure | ||||||
| 12/20/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Heart Failure | ||||||
| 09/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Travel and Lodging | Cash or cash equivalent | $434.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Opioid Analgesic | ||||||
| 02/06/2019 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $99.00 | General |
| 02/06/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: Opioid Analgesic | ||||||
| 11/15/2018 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Opioid Analgesic | ||||||
| 10/17/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Travel and Lodging | In-kind items and services | $3,875.84 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 10/17/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,555.00 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 10/17/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/15/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,555.00 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/15/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Travel and Lodging | In-kind items and services | $1,104.09 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/15/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $93.72 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/15/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $38.10 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/13/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Consulting Fee | Cash or cash equivalent | $1,185.00 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 06/20/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 06/20/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Travel and Lodging | In-kind items and services | $1,302.31 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 06/20/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $61.60 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 06/20/2018 | Collegium Pharmaceutical, Inc. | XtampzaER (Drug) | Education | In-kind items and services | $2.56 | General |
| Category: Opioid Analgesic | ||||||
| 06/08/2018 | Collegium Pharmaceutical, Inc. | XtampzaER (Drug) | Education | In-kind items and services | $2.56 | General |
| Category: Opioid Analgesic | ||||||
| 05/17/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,845.00 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 05/17/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $90.82 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 90 | 159 | $55,530 | $13,390 |
| 2022 | 5 | 127 | 220 | $83,025 | $18,678 |
| 2021 | 7 | 177 | 247 | $89,885 | $21,389 |
| 2020 | 9 | 196 | 269 | $85,775 | $19,259 |
Total Patients
590
Total Services
895
Medicare Billing
$72,716
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 52 | $18,460 | $5,231 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 44 | $16,500 | $3,210 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 34 | $8,500 | $2,274 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $7,520 | $1,761 | 23.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $4,550 | $914.42 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 84 | $31,500 | $6,305 | 20.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 52 | $18,460 | $4,475 | 24.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 27 | $12,690 | $3,067 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 25 | $12,375 | $2,917 | 23.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 32 | $8,000 | $1,914 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 53 | $18,815 | $4,656 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 36 | 55 | $20,625 | $4,606 | 22.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 28 | $13,860 | $3,410 | 24.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 25 | 28 | $13,160 | $3,238 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 42 | $10,500 | $2,567 | 24.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 25 | 26 | $9,100 | $2,231 | 24.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 15 | $3,825 | $680.76 | 17.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 21 | 43 | $15,265 | $3,770 | 24.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 58 | $14,500 | $3,493 | 24.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 34 | 37 | $12,950 | $3,284 | 25.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 24 | $11,880 | $2,125 | 17.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 22 | 27 | $10,125 | $1,850 | 18.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $8,055 | $1,830 | 22.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 18 | 18 | $5,525 | $1,238 | 22.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 26 | $4,815 | $1,027 | 21.3% |
About Dr. Andrew Putnam, MD
Dr. Andrew Putnam, MD is a Hospice and Palliative Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154307866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Putnam, MD has received a total of $160,229 in payments from pharmaceutical and medical device companies, with $21.84 received in 2024. These payments were reported across 142 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,290).
As a Medicare-enrolled provider, Putnam has provided services to 590 Medicare beneficiaries, totaling 895 services with total Medicare billing of $72,716. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Hematology & Oncology
- Location New Haven, CT
- Active Since 12/15/2005
- Last Updated 10/17/2012
- Taxonomy Code 207RH0002X
- Entity Type Individual
- NPI Number 1154307866
Products in Payments
- SYNDROS (Drug) $76,688
- SUBSYS (Drug) $60,100
- Xtampza ER (Drug) $18,905
- RELISTOR (Drug) $4,185
- Levorphanol (Drug) $98.42
- CARDIOMEMS (Device) $74.98
- XTAMPZA (Drug) $62.14
- XARELTO (Drug) $11.89
- XtampzaER (Drug) $5.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in New Haven
Sylvia Kurz, M.d., Ph.d, M.D., PH.D
Hospice and Palliative Medicine — Payments: $759.88
Hospice and Palliative Medicine $759.88
Mark Swidler, Md, MD
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Laura Morrison, Md, MD
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Dr. John Blanton, M.d, M.D
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Dr. Elizabeth Prsic, M.d, M.D
Hospice and Palliative Medicine
Hospice and Palliative Medicine
Vinay Rao
Hospice and Palliative Medicine
Hospice and Palliative Medicine